StonvexLoading…
StonvexStonvexStonvexCore line items from CBL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.29M | $16.24M | $11.48M | $7.47M |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $46.49M | $135.97M | $86.98M | $11.55M |
EPS (Diluted) | $1.48 | $4.34 | $2.78 | $0.35 |
Total Assets | $2.65B | $2.73B | $2.73B | $2.60B |
Total Liabilities | $2.26B | $2.36B | $2.39B | $2.33B |
Cash & Equivalents | $122.74M | $42.29M | $52.59M | $100.33M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 30.94M | 30.32M | 30.78M | 30.94M |